Cobicistat Tablets (Tybost): Complete Guide For HIV Treatment
Cobicistat (Tybost) boosts atazanavir or darunavir levels in HIV treatment regimens for adults and children.

About cobicistat tablets and how to take them if you are prescribed them for HIV treatment.
About cobicistat tablets
Cobicistat, sold under the brand name
Tybost
, is a medication used in the management of HIV-1 infection. It functions as aCYP3A inhibitor
(pharmacokinetic enhancer), which means it boosts the blood levels of certain antiretroviral drugs like atazanavir or darunavir by slowing their breakdown in the liver. This allows lower doses of these protease inhibitors to achieve effective concentrations, improving treatment outcomes while potentially reducing side effects.Unlike antiretrovirals that directly fight the virus, cobicistat has no direct anti-HIV activity on its own. It is always used in combination with other HIV medicines as part of antiretroviral therapy (ART). HIV treatment aims to reduce viral load, increase CD4 cell counts, and prevent progression to AIDS, though it does not cure the infection.
Tybost is available as oral tablets (150 mg) and is prescription-only, approved for adults and pediatric patients weighing at least 14 kg. In Europe, it is authorized for adolescents aged 12 years and older weighing at least 35 kg (with atazanavir) or 40 kg (with darunavir).
Key facts
- Cobicistat is also called Tybost®.
- It starts working straight away but full benefits in HIV control may take weeks with consistent use.
- Common side effects include nausea, diarrhea, and upper respiratory infections.
- Treatment is lifelong; stopping can lead to HIV rebound and resistance.
- Taken once daily with food to enhance absorption of partner drugs.
How does cobicistat work for HIV?
**Cobicistat** inhibits cytochrome P450 3A (CYP3A) enzymes in the liver and intestines, which normally metabolize drugs like atazanavir and darunavir. By blocking these enzymes, cobicistat increases the systemic exposure (blood levels) of these protease inhibitors, enabling once-daily dosing at lower amounts for sustained antiviral activity.
Protease inhibitors like atazanavir and darunavir block HIV protease, an enzyme essential for viral maturation. Enhanced levels ensure the virus cannot replicate effectively, reducing viral load to undetectable levels (<50 copies/mL) in most patients when combined with other ART agents. Clinical trials showed cobicistat-boosted regimens achieve viral suppression rates comparable to ritonavir-boosted ones (85-87% at 48 weeks).
This boosting effect also impacts other CYP3A-metabolized drugs, necessitating careful interaction management.
When is cobicistat prescribed for HIV?
Cobicistat is indicated to enhance atazanavir (300 mg once daily) or darunavir (800 mg once daily) in combination antiretroviral therapy for HIV-1 in:
- Adults.
- Pediatric patients ≥14 kg (specific formulations like single-tablet regimens may apply).
It is not approved for boosting darunavir 600 mg twice daily, fosamprenavir, saquinavir, or tipranavir due to insufficient data. Common regimens include Tybost with atazanavir/ritonavir alternatives in fixed-dose combinations like Genvoya, Stribild, or Symtuza.
Prescribed by HIV specialists when ritonavir is unsuitable (e.g., due to interactions or tolerability). Not for HIV-2 or monotherapy.
How and when to take cobicistat
Follow your doctor’s instructions precisely. Standard dosing:
| Patient Group | Dose | Instructions |
|---|---|---|
| Adults | 1 tablet (150 mg) once daily | With atazanavir 300 mg or darunavir 800 mg, plus other ART; take with food |
| Pediatrics (≥14 kg) | 150 mg once daily | With atazanavir or darunavir per weight-based guidelines; with food |
Swallow whole; do not chew, crush, or split. Take with a meal to boost absorption of boosted drugs (fatty food enhances bioavailability). If missed, take as soon as remembered unless near next dose—do not double. Store at room temperature, away from moisture.
Common questions about taking cobicistat
How long does it take to work?
Cobicistat boosts drug levels immediately, but HIV viral suppression typically occurs within 1-3 months of starting ART.
Can you drive or operate machinery?
Yes, but monitor for dizziness or fatigue initially.
Can you drink alcohol?
Moderate alcohol is generally okay but discuss with your doctor; excess may worsen liver side effects or interactions.
Is it safe in pregnancy?
Limited data; use only if benefits outweigh risks. Register in antiretroviral pregnancy registry.
Can it affect fertility?
No known impact on fertility in animal studies; human data limited.
Dosage
Adults: 150 mg orally once daily with atazanavir 300 mg or darunavir 800 mg (both once daily), and other antiretrovirals.
Children: For patients ≥14 kg, 150 mg once daily with appropriate doses of atazanavir or darunavir. Weight bands guide pediatric dosing.
No dose adjustment for mild-moderate kidney/liver impairment, but avoid in severe cases or with certain drugs. Always with food.
Side-effects
Most side effects are mild and from partner drugs. Common (>5%):
- Nausea, diarrhea, vomiting.
- Upper respiratory tract infection.
- Headache, fatigue.
Serious (rare):
- New or worsening kidney problems (monitor creatinine).
- Lactic acidosis, severe hepatomegaly with steatosis.
- Drug interactions causing toxicity (e.g., statins, sildenafil).
Report persistent symptoms to your doctor. Side effects often improve over time.
Pregnancy and breastfeeding
Pregnancy: Category B (no evidence of risk in animals); human studies ongoing. Use in pregnancy only if necessary.
Breastfeeding: HIV-positive mothers should not breastfeed to avoid transmission risk. Cobicistat enters breast milk in small amounts.
Cautions
- Kidney disease: Can increase serum creatinine; monitor eGFR.
- Liver issues: Use cautiously in HBV/HCV coinfection.
- Drug interactions: Strong CYP3A inhibitor; avoid with alfuzosin, lovastatin, sildenafil (for PAH), etc. Check interactions.
- Not for patients on rifampin or carbamazepine (induce CYP3A, reducing efficacy).
Other medicines, food, and cobicistat
Cobicistat interacts with many drugs metabolized by CYP3A or affecting renal transporters. Key examples:
| Drug Class | Examples | Advice |
|---|---|---|
| Antifungals | Ketoconazole | Dose limit |
| Statins | Simvastatin | Contraindicated |
| ED drugs | Sildenafil | Low dose only |
| Herbals | St. John’s wort | Do not use |
Provide full medication list to your doctor/pharmacist. Antacids separate by 2 hours.
Frequently asked questions
Will cobicistat cure HIV?
No, it enhances other drugs but does not cure HIV. Lifelong ART is required.
Can you stop taking it suddenly?
No, consult your doctor to avoid viral rebound.
Does it prevent HIV transmission?
Undetectable viral load (U=U) prevents transmission, but use condoms for STIs.
What if you miss a dose?
Take ASAP if <12 hours late; skip if near next dose.
Is generic available?
Brand-only currently; check with pharmacist.
References
- Cobicistat: Uses, Interactions, Mechanism of Action — DrugBank. 2024. https://go.drugbank.com/drugs/DB09065
- Tybost | European Medicines Agency (EMA) — EMA. 2023-09-21. https://www.ema.europa.eu/en/medicines/human/EPAR/tybost
- Cobicistat (Tybost) Fact Sheet — IAPAC. 2023. https://www.iapac.org/fact-sheet/cobicistat-tybost/
- Cobicistat (oral route) — Mayo Clinic. 2024-01-01. https://www.mayoclinic.org/drugs-supplements/cobicistat-oral-route/description/drg-20122653
- TYBOST (cobicistat) tablets Prescribing Information — Gilead Sciences. 2024. https://www.gilead.com/-/media/files/pdfs/medicines/hiv/tybost/tybost_pi.pdf
- TYBOST FDA Label — FDA. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203094s017s018lbl.pdf
Read full bio of medha deb
















